View in EDS

Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study.

Saved in:
Bibliographic Details
Title: Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study.
Authors: Serra-Bellver P; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom. Electronic address: p.serra@nhs.net., Versluis JM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Oberoi HK; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Zhou C; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, United Kingdom., Slattery TD; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom., Khan Y; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom., Patrinely JR; Department of Medical Oncology, Vanderbilt University Medical Center, Nashville, TN, USA., Pires da Silva I; Melanoma Institute Australia, The University of Sydney and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Westmead and Blacktown Hospital, Sydney, Australia., Martínez-Vila C; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Cook N; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, University of Manchester, United Kingdom., Graham DM; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, University of Manchester, United Kingdom., Carlino MS; Melanoma Institute Australia, The University of Sydney and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Westmead and Blacktown Hospital, Sydney, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia., Arance AM; Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Johnson DB; Department of Medical Oncology, Vanderbilt University Medical Center, Nashville, TN, USA., Long GV; Melanoma Institute Australia, The University of Sydney and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia., Pickering L; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom., Larkin JMG; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom., Blank CU; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Lorigan P; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, University of Manchester, United Kingdom.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Nov; Vol. 176, pp. 121-132. Date of Electronic Publication: 2022 Oct 07.
Publication Type: Multicenter Study; Journal Article
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36215945
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Serra-Bellver+P%22">Serra-Bellver P</searchLink>; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom. Electronic address: p.serra@nhs.net.<br /><searchLink fieldCode="AU" term="%22Versluis+JM%22">Versluis JM</searchLink>; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Oberoi+HK%22">Oberoi HK</searchLink>; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Zhou+C%22">Zhou C</searchLink>; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Slattery+TD%22">Slattery TD</searchLink>; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Khan+Y%22">Khan Y</searchLink>; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Patrinely+JR%22">Patrinely JR</searchLink>; Department of Medical Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Pires+da+Silva+I%22">Pires da Silva I</searchLink>; Melanoma Institute Australia, The University of Sydney and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Westmead and Blacktown Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Martínez-Vila+C%22">Martínez-Vila C</searchLink>; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Cook+N%22">Cook N</searchLink>; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, University of Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Graham+DM%22">Graham DM</searchLink>; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, University of Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Carlino+MS%22">Carlino MS</searchLink>; Melanoma Institute Australia, The University of Sydney and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Westmead and Blacktown Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Menzies+AM%22">Menzies AM</searchLink>; Melanoma Institute Australia, The University of Sydney and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Arance+AM%22">Arance AM</searchLink>; Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Johnson+DB%22">Johnson DB</searchLink>; Department of Medical Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Long+GV%22">Long GV</searchLink>; Melanoma Institute Australia, The University of Sydney and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Pickering+L%22">Pickering L</searchLink>; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Larkin+JMG%22">Larkin JMG</searchLink>; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Blank+CU%22">Blank CU</searchLink>; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Lorigan+P%22">Lorigan P</searchLink>; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, University of Manchester, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2022 Nov; Vol. 176, pp. 121-132. <i>Date of Electronic Publication: </i>2022 Oct 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Multicenter Study; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36215945
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejca.2022.09.004
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 121
    Titles:
      – TitleFull: Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Serra-Bellver P
      – PersonEntity:
          Name:
            NameFull: Versluis JM
      – PersonEntity:
          Name:
            NameFull: Oberoi HK
      – PersonEntity:
          Name:
            NameFull: Zhou C
      – PersonEntity:
          Name:
            NameFull: Slattery TD
      – PersonEntity:
          Name:
            NameFull: Khan Y
      – PersonEntity:
          Name:
            NameFull: Patrinely JR
      – PersonEntity:
          Name:
            NameFull: Pires da Silva I
      – PersonEntity:
          Name:
            NameFull: Martínez-Vila C
      – PersonEntity:
          Name:
            NameFull: Cook N
      – PersonEntity:
          Name:
            NameFull: Graham DM
      – PersonEntity:
          Name:
            NameFull: Carlino MS
      – PersonEntity:
          Name:
            NameFull: Menzies AM
      – PersonEntity:
          Name:
            NameFull: Arance AM
      – PersonEntity:
          Name:
            NameFull: Johnson DB
      – PersonEntity:
          Name:
            NameFull: Long GV
      – PersonEntity:
          Name:
            NameFull: Pickering L
      – PersonEntity:
          Name:
            NameFull: Larkin JMG
      – PersonEntity:
          Name:
            NameFull: Blank CU
      – PersonEntity:
          Name:
            NameFull: Lorigan P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2022 Nov
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0852
          Numbering:
            – Type: volume
              Value: 176
          Titles:
            – TitleFull: European journal of cancer (Oxford, England : 1990)
              Type: main
ResultId 1